PCA3 in Prostate Cancer.

Methods Mol Biol

Department of Urology, GB Morgagni Hospital, Forlì, Italy.

Published: April 2021

Prostate cancer antigen 3 (PCA3) is a urinary biomarker for prostate cancer and has demonstrated a good specificity and sensitivity representing a minimally invasive test.PCA3 assay could be useful in combination with PSA to suggest an eventual rebiopsy in men who have had one or more previous negative prostate biopsies.Combination of multiple tumor biomarkers will be the trend in the near future to achieve the goal of evaluate the aggressiveness of cancer and at the same time reducing the number of unnecessary biopsies.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-0716-1354-2_9DOI Listing

Publication Analysis

Top Keywords

prostate cancer
12
pca3 prostate
4
cancer
4
cancer prostate
4
cancer antigen
4
antigen pca3
4
pca3 urinary
4
urinary biomarker
4
biomarker prostate
4
cancer demonstrated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!